Press Releases
April 30, 2025
Waiver exempts NRx from paying a $4.3 million New Drug Application filing fee under the Prescription Drug User Fee Act (PDUFA) Company is on track for...
Olean Times Herald
Press Releases
March 17, 2025
WILMINGTON, Del. , March 17, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage bi...
Press Releases
March 12, 2025
- Conference call to take place at 8:30am ET - WILMINGTON, Del. , March 12, 2025 /PRNewswire/ --NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmac...
Press Releases
February 3, 2025
MIAMI , Feb. 3, 2025 /PRNewswire/ -- HOPE Therapeutics™, Inc. ("HOPE"), a medical and technology driven company, and a wholly-owned subsidiary of NRx ...
Press Releases
January 13, 2025
WILMINGTON, Del. , Jan. 13, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) ("NRx", the "Company"), a clinical-stage biopharmaceutical c...
Press Releases
January 10, 2025
MIAMI , Jan. 10, 2025 /PRNewswire/ -- HOPE Therapeutics™, Inc., ("HOPE"), a medical and technology driven company, and a wholly-owned subsidiary of NR...
Press Releases
January 7, 2025
MIAMI , Jan. 7, 2025 /PRNewswire/ -- HOPE Therapeutics™, Inc., ("HOPE"), a medical and technology driven company and wholly-owned subsidiary ofNRx Pha...
Press Releases
January 6, 2025
MIAMI , Jan. 6, 2025 /PRNewswire/ -- HOPE Therapeutics, Inc., ("HOPE," the "Company"), a wholly-owned subsidiary of NRx Pharmaceuticals, Inc. ("NRx") ...
Press Releases
January 3, 2025
MIAMI , Jan. 3, 2025 /PRNewswire/ -- HOPE Therapeutics, Inc., an NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) subsidiary, is inviting Qualified Institutio...
